Timothy V. Pham

516 total citations
16 papers, 344 citations indexed

About

Timothy V. Pham is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Timothy V. Pham has authored 16 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Timothy V. Pham's work include Immune cells in cancer (5 papers), Immune Cell Function and Interaction (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Timothy V. Pham is often cited by papers focused on Immune cells in cancer (5 papers), Immune Cell Function and Interaction (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Timothy V. Pham collaborates with scholars based in United States, Taiwan and Netherlands. Timothy V. Pham's co-authors include Pablo Tamayo, Razelle Kurzrock, Aaron M. Goodman, Amélie Boichard, Huwate Yeerna, Shweta Joshi, Garrett M. Frampton, Paul Riviere, Scott M. Lippman and Dan S. Kaufman and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Analytical Chemistry.

In The Last Decade

Timothy V. Pham

15 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy V. Pham United States 11 152 143 121 75 37 16 344
Tomasz Adamus United States 9 127 0.8× 140 1.0× 248 2.0× 134 1.8× 55 1.5× 12 451
Negar Hosseinkhani Iran 11 227 1.5× 161 1.1× 105 0.9× 73 1.0× 43 1.2× 12 370
Raquel J. Nunes Portugal 8 110 0.7× 164 1.1× 138 1.1× 68 0.9× 47 1.3× 14 387
Paula Silva Spain 8 120 0.8× 100 0.7× 194 1.6× 55 0.7× 17 0.5× 17 372
Annie Xiao United States 10 152 1.0× 95 0.7× 123 1.0× 88 1.2× 67 1.8× 19 385
Jessie Brown United States 7 137 0.9× 85 0.6× 192 1.6× 64 0.9× 23 0.6× 11 344
Araci M. R. Rondon Netherlands 10 118 0.8× 124 0.9× 175 1.4× 79 1.1× 38 1.0× 18 416
Elisa Ruffo United States 7 250 1.6× 203 1.4× 131 1.1× 30 0.4× 61 1.6× 10 428
Priska Auf der Maur Switzerland 5 240 1.6× 174 1.2× 160 1.3× 96 1.3× 54 1.5× 6 412

Countries citing papers authored by Timothy V. Pham

Since Specialization
Citations

This map shows the geographic impact of Timothy V. Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy V. Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy V. Pham more than expected).

Fields of papers citing papers by Timothy V. Pham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy V. Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy V. Pham. The network helps show where Timothy V. Pham may publish in the future.

Co-authorship network of co-authors of Timothy V. Pham

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy V. Pham. A scholar is included among the top collaborators of Timothy V. Pham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy V. Pham. Timothy V. Pham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pham, Timothy V., et al.. (2025). Abstract LB071: Modulating TREM1 to boost NK cell activity and overcome MDSC-induced immunosuppression in neuroblastoma. Cancer Research. 85(8_Supplement_2). LB071–LB071.
2.
Park, In Hwan, Timothy V. Pham, Jonathan Weitz, et al.. (2023). Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma. Cancer Research. 83(16). 2675–2689. 21 indexed citations
3.
Park, In Hwan, et al.. (2023). Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma. Frontiers in Immunology. 14. 1148317–1148317. 7 indexed citations
4.
Bernareggi, Davide, Qi Xie, Briana C. Prager, et al.. (2022). CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity. Nature Communications. 13(1). 1899–1899. 46 indexed citations
5.
Kurniawan, Jonas, Jacob S. Prince, Brandon Ho, et al.. (2022). A flexible adhesive surface electrode array capable of cervical electroneurography during a sequential autonomic stress challenge. Scientific Reports. 12(1). 19467–19467. 6 indexed citations
6.
Kurniawan, Jonas, et al.. (2022). Electrochemical performance study of Ag/AgCl and Au flexible electrodes for unobtrusive monitoring of human biopotentials. SHILAP Revista de lepidopterología. 3(8). 1277–1287. 6 indexed citations
7.
Kurniawan, Jonas, Andrew Shin, Timothy V. Pham, et al.. (2021). An Adhesive‐Integrated Stretchable Silver‐Silver Chloride Electrode Array for Unobtrusive Monitoring of Gastric Neuromuscular Activity. Advanced Materials Technologies. 6(5). 13 indexed citations
8.
Pham, Timothy V., et al.. (2021). BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma. Cancers. 13(4). 817–817. 18 indexed citations
9.
Pham, Timothy V., Aaron M. Goodman, Smruthy Sivakumar, Garrett M. Frampton, & Razelle Kurzrock. (2021). Intra-patient stability of tumor mutational burden from tissue biopsies at different time points in advanced cancers. Genome Medicine. 13(1). 159–159. 10 indexed citations
10.
Pouyanfard, Somayeh, Karin Diggle, Timothy V. Pham, et al.. (2021). Human Induced Pluripotent Stem Cell-Derived Macrophages Ameliorate Liver Fibrosis. Stem Cells. 39(12). 1701–1717. 34 indexed citations
11.
Moore, Colman, et al.. (2020). Multispectral Nanoparticle Tracking Analysis for the Real-Time and Label-Free Characterization of Amyloid-β Self-Assembly In Vitro. Analytical Chemistry. 92(17). 11590–11599. 20 indexed citations
12.
Joshi, Shweta, Kevin X. Liu, Muamera Zulcic, et al.. (2020). Macrophage Syk–PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk–PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression. Molecular Cancer Therapeutics. 19(3). 755–764. 28 indexed citations
13.
Pham, Timothy V., Amélie Boichard, Aaron M. Goodman, et al.. (2020). Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy. Molecular Oncology. 14(8). 1680–1694. 39 indexed citations
14.
Joshi, Shweta, Alok R. Singh, Kevin X. Liu, et al.. (2019). SF2523: Dual PI3K/BRD4 Inhibitor Blocks Tumor Immunosuppression and Promotes Adaptive Immune Responses in Cancer. Molecular Cancer Therapeutics. 18(6). 1036–1044. 41 indexed citations
16.
Boichard, Amélie, Timothy V. Pham, Huwate Yeerna, et al.. (2018). APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy. OncoImmunology. 8(3). 1550341–1550341. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026